Human Stem Cells Institute PJSC
A biotech investor developing gene therapy, regenerative medicine, and genetic services.
ISKJ | MOEX
Overview
Corporate Details
- ISIN(s):
- RU000A0JNAB6
- LEI:
- Country:
- Russian Federation
- Address:
- 3 Gubkina Street PO Box 373, 119333 Moscow
- Website:
- https://hsci.ru/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Artgen Biotech PJSC (formerly Human Stem Cells Institute PJSC) is a biotechnology company focused on developing and commercializing a portfolio of innovative platform technologies in healthcare. The company operates as a strategic investor, managing R&D projects and portfolio companies at various growth stages. Its core activities encompass the development of biomedical drugs (including gene therapy, vaccines, and antibodies), medical devices based on gene-activated materials for regenerative medicine, and advanced medical services such as biobanking and genetic research. Artgen fosters a biotech ecosystem to accelerate the development and market introduction of its innovations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Human Stem Cells Institute PJSC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Human Stem Cells Institute PJSC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
